文献速递神经创伤神经重症

口服抗凝药头部创伤患者迟发性颅内出血的发生率与危险因素:系统综述与荟萃分析

Incidence and Risk Factors of Delayed Intracranial Hemorrhage in Anticoagulated Head Trauma Patients: A Systematic Review and Meta-Analysis.
PubMed 文献 · World Neurosurg · 2024-09-10

该系统综述与荟萃分析纳入26项研究共7218例口服抗凝药的头部创伤患者,迟发性颅内出血总体发生率为2.0%,其中仅0.1%需神经外科干预、0.1%死亡。汇总分析显示维生素K拮抗剂每1000例风险人群中迟发性颅内出血27.1例,直接口服抗凝药20.5例;格拉斯哥昏迷评分<15、意识丧失、创伤后遗忘、简明损伤定级头部≥3为显著危险因素。

要点

  • 口服抗凝药头部创伤患者迟发性颅内出血总体发生率为2.0%。
  • 迟发性颅内出血需神经外科干预者占0.1%,死亡者占0.1%。
  • 格拉斯哥昏迷评分<15、意识丧失、创伤后遗忘、简明损伤定级头部≥3为显著危险因素。

核心结论

  • 迟发性颅内出血的发生率低,需要神经外科干预的比例也低;但需要进一步研究评估这些患者其他医疗管理的必要性。
  • 对高危患者进行选择性影像检查可改善诊疗并优化资源配置。

研究设计与样本

  • 系统综述与荟萃分析,遵循PRISMA和MOOSE指南。
  • 检索PubMed和Cochrane对照试验中心注册库,纳入在初次CT阴性后24小时内复查CT并报告迟发性颅内出血发生率的研究。
  • 从634篇文献中纳入26项研究,共7218例患者。

主要发现

  • 迟发性颅内出血总体发生率为2.0%,其中43.8%的病例需要住院或改变临床管理。
  • 仅0.1%需要神经外科干预,0.1%导致死亡。
  • 20项研究的荟萃分析显示,每1000例风险人群中迟发性颅内出血的汇总发生率:维生素K拮抗剂为27.1,直接口服抗凝药为20.5。
  • 迟发性颅内出血的显著危险因素包括格拉斯哥昏迷评分<15、意识丧失、创伤后遗忘和简明损伤定级头部≥3。

局限性

  • 需要进一步研究评估这些患者其他医疗管理的必要性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aims to provide a current and comprehensive analysis of the incidence of delayed intracerebral hemorrhage (dICH) in head trauma patients on oral anticoagulants (ACs) and to evaluate various potential risk factors. METHODS: We conducted a systematic review and meta-analysis following Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Meta-Analysis of Observational Studies in Epidemiology guidelines. PubMed and Cochrane Central Register of Controlled Trials were searched for studies on dICH in anticoagulated head trauma patients undergoing repeat computed tomography scans. Studies reporting dICH incidence on repeat computed tomography within 24 hours of an initial negative scan were included. Data on demographics, AC type, risk factors, and clinical outcomes were extracted and analyzed. RESULTS: From 634 identified articles, 26 studies with 7218 patients were included. The overall incidence of dICH was 2.0%, with 43.8% of these cases requiring hospital admission or changes in clinical management. Only 0.1% required neurosurgical intervention, and 0.1% resulted in death. Meta-analysis of 20 studies revealed pooled dICH incidence per 1000 persons at risk was 27.1 for vitamin K antagonists and 20.5 for direct oral ACs. Significant risk factors for dICH included Glasgow Coma Scale <15, loss of consciousness, post-traumatic amnesia, and Abbreviated Injury Scale head ≥3. CONCLUSIONS: A low incidence of dICH requires neurosurgical intervention; however, further studies are required to assess the need for other medical management in these patients. Furthermore, selective imaging for high-risk patients could improve care and resource allocation.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Pessôa RL, Garcia GM, Becker GG, et al. Incidence and Risk Factors of Delayed Intracranial Hemorrhage in Anticoagulated Head Trauma Patients: A Systematic Review and Meta-Analysis. World Neurosurg. 2024. PMID: 39265937. doi:10.1016/j.wneu.2024.09.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。